Assessment of ovarian function suppression (OFS)-containing adjuvant endocrine therapy in premenopausal women by Breast Cancer Index
   Google Scholar   
Citation:
Meeting Instance:
ASCO 2025
Year:
2025
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
4696  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer; Biotheranostics, Inc.  
Grants:
U10CA180821; U10CA180863 and CCS 707213 (CCTG);  
Corr. Author:
 
Authors:
                                 
Networks:
LAPS-IL057, NY167, OH070   
Study
IBCSG-25-02 (TEXT)
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: